Biogen Inc.: BofA Global Research raises price objective to $244 from $219
BIIB•BofA Global Research raised its price objective for Biogen to $244 from $219.
Related News
Bernstein raises IBM target price to $250 from $230
IBM•
BlackRock increases total voting rights in Symrise to 9.40% from 9.26%
BLK•
Canada's Carney visits Turkey in push to ease US trade dependence
SPY•
Gold hits over two-week low as oil rally fuels inflation worries
GLD•
CME Group target price raised to $359 from $337
CME•